SJSR



Doctor Mouna AYADIDIPLOMASANDSCIENTIFIC WORKCIVILITY?:Name : AyadiFirst name : MounaDate and place of birth: 28/05/1976 in Tunis – Tunisia.Nationality: TunisianMarital status: married to Nabil OuardaCOORDINATES?:Address : 24 rue Menzel Bourguiba borjBaccouche 2080 ariana TunisieTel?: 00?216 98338225Mail?: mounaayadi28@DEGREES AND DIPLOMAS:BA: Section Mathématique : June 1994With honors State doctorate in medicine?:Date and place of production: june 2004 Faculty of Medicine of Tunis. Title: “peritoneal stromal tumor”Mention: honorable mention and felicitation of the jury-National diploma of specialist in Medical Oncology: Date and place of production: October 2007 Tunis. -Hospital and university assistant in Medical Oncology at Salah Azaiez Institute tunisDate and place of production: OCTOBER 2011 Tunis.SCHOOL: - Date and place of beginning medical studies: Faculty of Medicine of Tunis: September 1994 - June 1999- Competition residency in medicine: - Session December 2002- Specialty: Medical Oncology.- Date and place of access to specialized studies : From 1 JULY 2003 to 31december 2003, 6 months, Medical oncology, salahazaizinstitute,Tunis, Tunisia From 1 January2004 to 30 juin2004, 6 months, Hematology,Anathomopathology, alahazaizinstituteTunis, Tunisia.From 1 July2004 to 31december2004, 6 months, hematology, centre de greffe de moelleosseuseTunis, Tunisia.From 1 January 2005 to 6 November 2005, Internal Medecine, Salah azaiz institute, Tunis, Tunisia.From 8 november 2005 to 31 May2006, 6 ??months, Medical Oncology,Institut Paoli Calmettes, Marseille, France From 31 May2007 to 31 Otober2007, hematology, Institut Paoli Calmettes, Marseille, France MEMORIES AND THESIS:Thesis : Date and place of production: June 2004 Faculty of Medicine of Tunis. Title : peritoneal stromal tumorMention: Honorable mention and felicitation of the juryPost-graduate degree:“Dipl?me Universitaire de cancérologie Clinique” :Gustave ROUSSY Institute (2007)??Dipl?me de Statistique CESAM Université Paris V (méthodologie en statistique et statistique appliqué aux essais cliniques)???:2007/2008 “Diploma in “Leadership and Management in health” .University of Washington (2016)EXPERIENCE?:Medical Oncologist in Salah Azaiez Institute since 2007ASSISTANT(CONSULTANT) on the faculty of medicine of Tunis since october 2011Professor associate since December 2017HOSPITALACTIVITY?:Consultation and Day hospitalPediatric oncologyOutpatient treatment Oncologic emergency and night shiftsMulti-disciplinary staff: breast cancer, digestive cancer, Urologic cancer, gynecologic cancer.ACADEMICACTIVITY?:Supervision of student internships, 3th years, Medical Oncology interns and residents.University teaching at the medical school of TunisMEMBERSHIP IN PROFESSIONAL SOCIETIES: The European society of medical oncology (ESMO) 2016The American society of medical oncology (ASCO) 2017The Tunisian society of medical oncology (STOM) 2013 and as general secretary since 2016GETUC member since 2016HOSPITAL-UNIVERSITY ACTIVITIES AND RESEARCHCO-INVESTIGATRICE IN 3 CLINICAL TRIAL?:Proselica trial?: étude phase III comparant cabazitaxel 20mg/m2 versus 25mg/m2 chez les patients atteints de cancer de la prostate hormono résistants et après échec du docetaxellym 3002 trial?: étude phase III comparant velcade CHOP versus placeboCHOP dans les lymphomes du manteau phase II?trial : immunothérapie dans les lymphomes folliculaires chez les patients en rechute après au moins une ligne de chimiothérapie ayant contenu du rituximabPUBLICATIONS?:“Primary leiomyosarcoma of thyroid gland : the youngest case”M Ayadi, AGabsi, K Meddeb, A Mokrani, Y Yahyaoui, F Letaief, N Chraiet, H Rais, A MezliniPanAfrican Medical Journal. 2017 ;26 :113 doi : 1011604/pamj.2017.26.113.11472“Breast angiosarcoma : A case report and review of literature”M Ayadi, Y Berrazegua, O Adouni, K Meddeb, O Gamoudi, Mezlini AInternational Journal of Case Reports ans Images (IJCRI), publié le 07 juillet 2017“Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma : a single center experience”F Letaief , M Nasri, M Ayadi, K Meddeb, A Mokrani, Y Yahiaoui, N Chraiet, H Raies, A MezliniCancer biology and medecine , 2095-3941.2017.0037“Two years survival of primary cardiac leiomysarcoma managed by surgical and adjuvant therapy”K Behi, M Ayadi, E Mezni, K Meddeb, A Mokrani, Y Yahiaoui, F Ksontini, H Raies, N Chraiet, A MezliniClinical sarcoma research , 2017.7: 5-“Larynx preservation: What is the best non-surgical strategy?”Lagha A, Chraiet N, Labidi S, Rifi H, Ayadi M, Krimi S, Allani B, Raies H, Touati S, Boussen H, Kochbati L, Mezlini A.Bulletin du cancer 2013 May; 100(5):465-71.-“Impact of Taxanes in the adjuvant setting of node-negative breast cancers”.Lagha A, Chraiet N, Labidi S, Krimi S, Ayadi M, Gligorov J, Boussen HTunisiemédicale 2013 Mar; 91(3):205-8.-“Carcinoma of unknown primary: retrospective study about 437 patients treated at Salah Azaiez Institute”.Fehri R, Rifi H, Alboueiri A, Malouche D, Ayadi M, Rais H, Mezlini A.Oral oncol 2012 Oct;48(10):948-57. -“Systemic therapy in the management of metastatic or advanced salivary gland cancers”.Lagha A, Chraiet N, Ayadi M, Krimi S, Allani B, Rifi H, Raies H, Mezlini A.Bulletin du cancer 2012 Apr 1;99(4):425-30. -“Primary small intestinal lymphoma: epidemiological, histological and therapeutic transition in Tunisia”.Belaid I, Mezlini A, Rais H, Jaafoura MH, Boussen H, Rifi H, Ayadi M, Chraiet N, Daoud N, El Benna H, Ayed FB.Am j case Rep, 2012;13:254-7. -“Primary anorectal melanoma: A case report with extended follow-up”.Lagha A, Ayadi M, Krimi S, Chraiet N, Allani B, Rifi H, Raies H, Mezlini A.Tunisie médicale 2011 Aug-Sep;89(8-9):699-702.-“Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy”.Ayadi S, Ksantini R, Maghrebi H, Daghfous A, Ayadi M, Fteriche F, Bedioui H, Chebbi F, Amous A, Jouini M, Kacem M, Mezlini A, Ben Safta Z.BMC cancer 2008 Jun 10;8:169. -“A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment”.Gon?alves A, Esteyries S, Taylor-Smedra B, Lagarde A, Ayadi M, Monges G, Bertucci F, Esterni B, Delpero JR, Turrini O, Lelong B, Viens P, Borg JP, Birnbaum D, Olschwang S, Viret F.Gastro enterolclin boil, 2008 Jun 10; 8:169. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download